Skip to main content
SpringerLink
Log in
Book cover

Structural Bioinformatics: Applications in Preclinical Drug Discovery Process

  • Book
  • © 2019

Overview

Editors:
  1. C. Gopi Mohan

    1. Amrita Centre for Nanosciences and Molecular Medicine, Amrita Institute of Medical Sciences and Research Centre, Kochi, India

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Examines successes, risks, and challenges of in-silico drug discovery
  • Offers integrated case studies, including a discussion of drug resistance with respect to structure-based drug design
  • Reviews the application of big data in drug discovery

Part of the book series: Challenges and Advances in Computational Chemistry and Physics (COCH, volume 27)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (12 chapters)

  1. Front Matter

    Pages i-xii
    Download chapter PDF

  2. Free Energy-Based Methods to Understand Drug Resistance Mutations

    • Elvis A. F. Martis, Evans C. Coutinho
    Pages 1-24

  3. Pharmacophore Modelling and Screening: Concepts, Recent Developments and Applications in Rational Drug Design

    • Chinmayee Choudhury, G. Narahari Sastry
    Pages 25-53

  4. Analysis of Protein Structures Using Residue Interaction Networks

    • Dmitrii Shcherbinin, Alexander Veselovsky
    Pages 55-69

  5. Combinatorial Drug Discovery from Activity-Related Substructure Identification

    • Md. Imbesat Hassan Rizvi, Chandan Raychaudhury, Debnath Pal
    Pages 71-108

  6. In Silico Structure-Based Prediction of Receptor–Ligand Binding Affinity: Current Progress and Challenges

    • Shailesh Kumar Panday, Indira Ghosh
    Pages 109-175

  7. Structure-Based Drug Design of PfDHODH Inhibitors as Antimalarial Agents

    • Shweta Bhagat, Anuj Gahlawat, Prasad V. Bharatam
    Pages 177-220

  8. Recent Advancements in Computing Reliable Binding Free Energies in Drug Discovery Projects

    • N. Arul Murugan, Vasanthanathan Poongavanam, U. Deva Priyakumar
    Pages 221-246

  9. Integrated Chemoinformatics Approaches Toward Epigenetic Drug Discovery

    • Saurabh Loharch, Vikrant Karmahapatra, Pawan Gupta, Rethi Madathil, Raman Parkesh
    Pages 247-269

  10. Structure-Based Drug Design with a Special Emphasis on Herbal Extracts

    • D. Velmurugan, N. H. V. Kutumbarao, V. Viswanathan, Atanu Bhattacharjee
    Pages 271-305

  11. Impact of Target-Based Drug Design in Anti-bacterial Drug Discovery for the Treatment of Tuberculosis

    • Anju Choorakottayil Pushkaran, Raja Biswas, C. Gopi Mohan
    Pages 307-346

  12. Turbo Analytics: Applications of Big Data and HPC in Drug Discovery

    • Rajendra R. Joshi, Uddhavesh Sonavane, Vinod Jani, Amit Saxena, Shruti Koulgi, Mallikarjunachari Uppuladinne et al.
    Pages 347-374

  13. Single-Particle cryo-EM as a Pipeline for Obtaining Atomic Resolution Structures of Druggable Targets in Preclinical Structure-Based Drug Design

    • Ramanathan Natesh
    Pages 375-400

  14. Back Matter

    Pages 401-406
    Download chapter PDF
Back to top

Keywords

About this book

This book reviews the advances and challenges of structure-based drug design in the preclinical drug discovery process, addressing various diseases, including malaria, tuberculosis and cancer. Written by internationally recognized researchers, this edited book discusses how the application of the various in-silico techniques, such as molecular docking, virtual screening, pharmacophore modeling, molecular dynamics simulations, and residue interaction networks offers insights into pharmacologically active novel molecular entities. It presents a clear concept of the molecular mechanism of different drug targets and explores methods to help understand drug resistance. In addition, it includes chapters dedicated to natural-product- derived medicines, combinatorial drug discovery, the CryoEM technique for structure-based drug design and big data in drug discovery.


The book offers an invaluable resource for graduate and postgraduate students, as well as forresearchers in academic and industrial laboratories working in the areas of chemoinformatics, medicinal and pharmaceutical chemistry and pharmacoinformatics.

Editors and Affiliations

  • Amrita Centre for Nanosciences and Molecular Medicine, Amrita Institute of Medical Sciences and Research Centre, Kochi, India

    C. Gopi Mohan

About the editor

Dr. C. Gopi Mohan is an Associate Professor at the Center for Nanosciences and Molecular Medicine, specializing in the areas of structural bioinformatics, structure-based drug design, protein crystallography, and nanoinformatics. He graduated from Banaras Hindu University with a PhD in Physics and gained experience as a postdoctoral researcher at the Indian Institute of Science, Bangalore (India), as a research officer at the University of Bath (UK) and as an associate researcher at the University Henri Poincare, Nancy (France). Further, he worked as a member of the faculty at the National Institute of Pharmaceutical Education & Research (NIPER), Mohali, Punjab. Dr. Gopi Mohan has published more than 70 research papers in refereed journals and was cited as an internationally recognized expert in the field of Structural Bioinformatics and Chemoinformatics by Synergix Ltd. (UK) founded by Dr. N.C. Cohen, a pioneer of rational drug design. Recently he was awarded the ICMR Senior Biomedical Scientist International Fellowship to visit US laboratories for research collaborations.

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation